向上滑动阅览 1) Penault-Llorca F, Radosevic-Robin N. Ki67 assessment in breast cancer: an update. Pathology. 2017 Feb;49(2):166-171. 2) Nielsen TO, Leung SCY, Rimm DL, et al. Assessment of Ki67 in Breast Cancer: Updated Recommendat...
The Breast Cancer Working Group Presentation was Divided into Three Sections :The Epidemiology,Pathology and Treatment of Breast Cancer[J]. Jpn J Clin Oncol 2010; 40 (Supplement 1): i13–i18. [5] Kim DK, Kim DW, Kim SW, et al K i67 antigen as a predictive factor for prognosis of ...
Rosemary L BalleineWestmead Breast Cancer InstituteJournal of Clinical PathologyPathmanathan N, Balleine RL. 2013. Ki67 and proliferation in breast cancer. J Clin Pathol 66:512-516.Pathmanathan N, Balleine RL. Ki67 and proliferation in breast cancer. J Clin Pathol. 2013; 66(6): 512-6....
2022年的USCAP乳腺病理有2个以Ki67检测为主要内容的口头发言,分别为来自美国斯隆凯特林癌症纪念中心的Melissa Krystel-Whittemore教授团队的“The Utility of Ki67 Quantification to Triage OncotypeDX Testing in Breast Cancer”和韩国首尔多家...
chemotherapy for breast cancerWU Yu-ye HUANG Mei-ling PAN Miao-junDepartment of Medical Oncology,Agribusiness Central Hospital of Guangdong Province,Zhanjiang 524000,China[Abstract] Objective To explore the relationship between Ki67 expression and curative effect of neoadjuvantchemotherapy for breast cancer....
[Key words] Ki67;Expression;Breast cancer;Neoadjuvant chemotherapy;Relationship 乳腺癌是肿瘤科临床常见病、多发病,其治疗越来越受到人们的重视。目前治疗方法多为:术前化疗-手术切除-术后化放疗,新辅助化疗(neoadjuvant chem-otherapy,NC)指术前化疗。NC能缩小肿瘤体积,还可降低区域淋巴结分期,利于患者预后。Ki67与...
对于结直肠癌(colorectal cancer,CRC)的Ki67 LI分级标准,也存在争议。 根据两个大型多中心前瞻性临床研究的结果,欧洲病理学家联合会(European Society of Pathology,ESP)推荐了以下分级标准: Ⅰ级:Ki67 LI<10% Ⅱ级:Ki67 LI10%-20% Ⅲ级:Ki67 LI>20% ...
才能正确判断乳腺浸润性导管癌癿预后关键字:乳腺癌;浸润性导管癌;Ki 67;病理学;预后【Abstract】ObjectiveToinvestigatetheexpressionandclinicopathologicalsignificanceofKi 67inbreastinvasiveductalcarcinoma.MethodsS PimmunohistochemicalstainingwasperformedtoexaminetheexpressionofKi 67in60casesofbreastinvasiveductalTheexpression...
Methods From January 2010 to January 2014,80 patients with breast cancer accepted neoadjuvant chemotherapy and treated in our hospital were selected.Patients were divided into high expression group (n=57) and low expression group (n=23) according to positive cell proportion of Ki67;patients were ...
Department ofPathology,Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025 , China[Abstract] Objective To investigate the changes in Ki67 expression in the patients with breast cancer molecularsubtypes between core needle biopsy (CNB) and surgical excision specimens. Methods...